Return to the home page of the Diabetes Monitor
insulin aspart (Novolog)
Advertisement



 






go to home page

read about us

contact us

read our disclaimer

go to the index

read our mission statement

read our privacy policy

search our website

go to the site map

find out what's new


































Novolog® (insulin aspart) is available in both Europe and the USA. It
is a synthetic rapid-lasting insulin product.







Insulin aspart


    

  • Brand name in US: Novolog®

  • Brand name in Europe: NovoRapid®

  • Class: insulin 
analog

  • For: insulin-treated diabetes

  • Route of Administration: subcutaneous

  • Action: short-acting insulin

  • manufacturer: 
Novo Nordisk Pharmaceuticals

  • Other drugs with approximately the same duration of action: 

Insulin glulisine (Apidra®),
Insulin lispro (Humalog®).








Also see




 
New rapid-acting insulin 
analogue, NovoLog®, now available in the US
18 September 2001.
Press Release from 
Novo Nordisk. 



 
NovoRapid®
from 
Novo Nordisk. For Health Professionals only.


 
NovoLog®
from 
Novo Nordisk.





















 



Search the DiabetesMonitor
for more information about 





 





























Advertisements





























 


[Top]
 



Webpage updated at the
DiabetesMonitor





21Aug2004



 



Advertisement












 












Return to the home page of the Diabetes Monitor


Go to the index


Search this website


Go to the site map


Read our copyright noticeRead our copyright notice


Send us an e-mail at info@diabetesmonitor.com